Biocept, Inc. (NASDAQ:BIOC) will hold its 2Q20 earnings conference call with the financial community on 12th August 2020 at 4:30 PM Eastern Time.
The conference call will be webcast live on Internet at www.biocept.com
Earnings Expectation
Biocept, Inc. developers of proprietary circulating tumor cell, is expected to report second quarter earnings results, after market close, on Wednesday 12th August 2020.
Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. The companys cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring in order to identify resistance mechanisms. It offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer, small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, melanoma, pancreatic biliary cancer, and ovarian cancer.
